Diagnostic accuracy of a rapid urine lipoarabinomannan test for tuberculosis in HIV-infected adults

Journal of Acquired Immune Deficiency Syndromes

Volumn 66, Issue 3, 2014, Pages 270-279

  Nakiyingi, Lydia ^a   Moodley, Vineshree Mischka ^b,c   Manabe, Yukari C ^a,d   Nicol, Mark P ^b,c   Holshouser, Molly ^d   Armstrong, Derek T ^d   Zemanay, Widaad ^b,c   Sikhondze, Welile ^b,c   Mbabazi, Olive ^a   Nonyane, Bareng A S ^d   Shah, Maunank ^d   Joloba, Moses L ^a   Alland, David ^e   Ellner, Jerrold J ^f   Dorman, Susan E ^d  

^a MAKERERE UNIVERSITY   (Uganda)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^f BOSTON MEDICAL CENTER   (United States)

Author keywords

Diagnosis; HIV; Opportunistic infections; Sensitivity and specificity; Tuberculosis

Indexed keywords

LIPOARABINOMANNAN; LIPOPOLYSACCHARIDE;

ADULT; ARTICLE; BACTERIUM CULTURE; BLOOD CULTURE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MICROSCOPY; MULTICENTER STUDY; MYCOBACTERIUM TUBERCULOSIS; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RAPID URINE LIPOARABINOMANNAN TEST; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SOUTH AFRICA; SPUTUM SMEAR; TUBERCULOSIS RAPID TEST; UGANDA; URINE; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CLINICAL TRIAL; COMPLICATION; DIAGNOSTIC TEST; HOSPITAL INFORMATION SYSTEM; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; PROCEDURES; STANDARDS; TUBERCULOSIS;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; BACTERIOLOGICAL TECHNIQUES; DIAGNOSTIC TESTS, ROUTINE; FEMALE; HIV INFECTIONS; HUMANS; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; POINT-OF-CARE SYSTEMS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS;

EID: 84922395137     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0000000000000151     Document Type: Article

References (36)

1. World Health Organization. Global tuberculosis report 2012. Available at: http://www.who.int/tb/publications/global-report/en/index.html. Accessed February 8, 2013.
2. Getahun H, Gunneberg C, Granich R, et al. HIV infection-associated tuberculosis: the epidemiology and the response. Clin Infect Dis. 2010;50(suppl 3):S201-S207.
3. Kyeyune R, Den Boon S, Cattamanchi A, et al. Causes of early mortality in HIV-infected TB suspects in an East African referral hospital. J Acquir Immune Defic Syndr. 2010;55:446-450.
4. Chamie G, Luetkemeyer A, Walusimbi-Nanteza M, et al. Significant variation in presentation of pulmonary tuberculosis across a resolution of CD4 strata. Int J Tuberc Lung Dis. 2010;14:1295-1302.
5. Getahun H, Harrington M, O'Brien R, et al. Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes. Lancet. 2007;369:2042-2049.
6. Boehme CC, Nabeta P, Hillemann D, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med. 2010;363:1005-1015.
7. Creswell J, Codlin AJ, Andre E, et al. Results from early programmatic implementation of Xpert MTB/RIF testing in nine countries. BMC Infect Dis. 2014;14:2.
8. Blanc FX, Sok T, Laureillard D, et al. Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis. N Engl J Med. 2011;365:1471-1481.
9. Havlir DV, Kendall MA, Ive P, et al. Timing of antiretroviral therapy for HIV-infection and tuberculosis. N Engl J Med. 2011;365:1482-1491.
10. Abdool Karim SS, Naidoo K, Grobler A, et al. Integration of antiretroviral therapy with tuberculosis treatment. N Engl J Med. 2011;365:1492-1501.
11. Brennan PJ. Structure, function, and biogenesis of the cell wall of Mycobacterium tuberculosis. Tuberculosis (Edinb). 2003;83:91-97.
12. Shah M, Variava E, Holmes CB, et al. Diagnostic accuracy of a urine lipoarabinomannan test for tuberculosis in hospitalized patients in a High HIV prevalence setting. J Acquir Immune Defic Syndr. 2009;52:145-151.
13. Lawn SD, Edwards DJ, Kranzer K, et al. Urine lipoarabinomannan assay for tuberculosis screening before antiretroviral therapy diagnostic yield and association with immune reconstitution disease. AIDS. 2009;23:1875-1880.
14. Dheda K, Davids V, Lenders L, et al. Clinical utility of a commercial LAM-ELISA assay for TB diagnosis in HIV-infected patients using urine and sputum samples. PLoS One. 2010;5:e9848.
15. Daley P, Michael JS, Hmar P, et al. Blinded evaluation of commercial urinary lipoarabinomannan for active tuberculosis: a pilot study. Int J Tuberc Lung Dis. 2009;13:989-995.
16. Gounder CR, Kufa T, Wada NI, et al. Diagnostic accuracy of a urine lipoarabinomannan enzyme-linked immunosorbent assay for screening ambulatory HIV-infected persons for tuberculosis. J Acquir Immune Defic Syndr. 2011;58:219-223.
17. Minion J, Leung E, Talbot E, et al. Diagnosing tuberculosis with urine lipoarabinomannan: systematic review and meta-analysis. Eur Respir J. 2011;38:1398-405.
18. WHO. Global TB Programme, World Health Organization. Laboratory services in TB control, Part II: microscopy. WHO/TB/98.258. Available at: http://whqlibdoc.who.int/hq/1998/WHO-TB-98.258-(part2).pdf Accessed January 20, 2013.
19. Kent PT, Kubica GP. Public Health Mycobacteriology: A Guide for the Level III Laboratory. Atlanta, GA: Centers for Disease Control; 1985.
20. Crump JA, Tanner DC, Mirrett S, et al. Controlled comparison of BACTEC 13A, MYCO F/LYTIC, BacT/ALERT MB, and ISOLATOR 10 systems for detection of mycobacteremia. J Clin Microbiol. 2003;41:1987-1990.
21. Crump JA, Morrissey AB, Ramadhani HO, et al. Controlled comparison of BacT/Alert MB system, manual Myco/F lytic procedure, and isolator 10 system for diagnosis of Mycobacterium tuberculosis bacteremia. J Clin Microbiol. 2011;49:3054-3057.
22. Alere. Determine TB LAM specifications and Package Insert. Available at: http://alerehiv.com/hiv-comorbidities/specifications/. Accessed February 24, 2013.
23. Treatment Action Group, Medecins Sans Frontieres. Paris meeting on TB point-of-care test specifications, 2009. Available at: http://www.msfaccess.org/TB-POC-Parismeeting/. Accessed February 18, 2013.
24. Mukundan H, Kumar S, Price DN, et al. Rapid detection of Mycobacterium tuberculosis biomarkers in a sandwich immunoassay format using a waveguide-based optical biosensor. Tuberculosis (Edinb). 2012;92:407-416.
25. Ferrara F, Naranjo LA, Kumar S, et al. Using phage and yeast display to select hundreds of monoclonal antibodies: application to antigen 85, a tuberculosis biomarker. PLoS One. 2012;7:e49535.
26. Lawn SD. Point-of-care detection of lipoarabinomannan (LAM) in urine for diagnosis of HIV-associated tuberculosis: a state of the art review. BMC Infect Dis. 2012;12:103.
27. Wood R, Racow K, Bekker LG, et al. Lipoarabinomannan in urine during tuberculosis treatment: association with host and pathogen factors and mycobacteriuria. BMC Infect Dis. 2012;12:47.
28. Lawn SD, Kerkhoff AD, Vogt M, et al. High diagnostic yield of tuberculosis from screening urine samples from HIV-infected patients with advanced immunodeficiency using the Xpert MTB/RIF assay. J Acquir Immune Defic Syndr. 2012;60:289-294.
29. Peter JG, Theron G, Muchinga TE, et al. The diagnostic accuracy of urine-based Xpert MTB/RIF in HIV-infected hospitalized patients who are smear-negative or sputum scarce. PLoS One. 2012;7:e39966.
30. Lawn SD, Kerkhoff AD, Vogt M, et al. HIV-associated tuberculosis: relationship between disease severity and the sensitivity of new sputum-based and urine-based diagnostic assays. BMC Med. 2013;11:231.
31. Lawn SD, Kerkhoff AD, Vogt M, et al. Diagnostic accuracy of a lowcost, urine antigen, point-of-care screening assay for HIV-associated pulmonary tuberculosis before antiretroviral therapy: a descriptive study. Lancet Infect Dis. 2012;12:201-209.
32. Peter JG, Theron G, Van Zyl-Smit R, et al. Diagnostic accuracy of a urine lipoarabinomannan strip-test for TB detection in HIV-infected hospitalised patients. Eur Respir J. 2012;40:1211-1220.
33. Peter JG, Theron G, Dheda K. Can point-of-care urine LAM strip testing for tuberculosis add value to clinical decision making in hospitalized HIV-infected persons? PLoS One. 2013;8:e54875.
34. Bossuyt PM, Reitsma JB, Bruns DE, et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD Initiative. Ann Intern Med. 2003;138:40-44.
35. Whiting P, Rutjes AWS, Westwood ME, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155:529-536.
36. Sun D, Dorman S, Shah M, et al. Cost utility of lateral-flow urine lipoarabinomannan for tuberculosis diagnosis in HIV-infected African adults. Int J Tuberc Lung Dis. 2013;17:552-558.